在日本,2型糖尿病中增加酸奶摄入量的成本效益
Ryota Wakayama1,2, Michihiro Araki1,3, Mieko Nakamura1
1National Institute of Health and Nutrition, National Institutes of Biochemical Innovation, Health and Nutrition, 3-17 Senriokashimmachi, Settsu 566-0002, Osaka, Japan.
Nutrients
|July 30, 2025
概括
增加酸奶摄入量可以显著降低2型糖尿病 (T2D) 风险,并降低日本的医疗保健成本. 这种饮食改变为公众健康和经济利益提供了一个有希望的战略.
科学领域:
- 营养科学 营养科学
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 健康饮食对于预防非传染性疾病至关重要.
- 乳制品,特别是酸奶,与降低2型糖尿病 (T2D) 风险有关.
- 以前的元分析支持酸奶消费与T2D之间的反向关联.
研究的目的:
- 开发一个模拟模型来评估增加酸奶摄入量对T2D的影响.
- 评估较高的酸奶消费对日本T2D的潜在医疗和经济影响.
主要方法:
- 马尔科夫模型被用来模拟10年期间的结果.
- 这项研究的重点是40-79岁的日本人口.
- 预测包括T2D发病率,T2D死亡率和国家医疗保健支出 (NHE).
主要成果:
- 将酸奶摄入量增加到每天160克或每天80克,导致T2D发病率分别下降16.1%或5.9%.
- 与T2D相关的死亡率下降了1.6% (160克/天) 或0.6% (80克/天).
- 预计国家医疗保健支出将减少2.4%或0.9%随着酸奶摄入量的增加.
结论:
- 增加酸奶消费是预防T2D的可行策略.
- 增加酸奶摄入量表明,有可能大幅减少国家医疗保健支出.
- 侧重于酸奶的饮食干预措施可以有助于改善公共卫生结果和经济节省.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Management and Pharmacotherapy
393
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
393
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
422
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
422
Drugs for Treatment of Diarrhea-Predominant IBS
299
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
299
Oral Hypoglycemic Agents: Biguanides and Glitazones
304
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
304


